Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to compare the efficacy of hypertonic saline nebulization with adrenaline nebulization in the treatment of acute bronchiolitis in children. Main aim is to evaluate the following in both group of patients 1. Improvement in Wood-Downes clinical score (WDF score) in bronchiolitis 2. Length of Hospitalization


Clinical Trial Description

This is a double-blind clinical trial that will include all admitted patients with acute bronchiolitis, meeting inclusion criteria, admitted in Pediatrics department Combined Military Hospital Nowshera. Patients will be divided into two groups randomly. Group I patients will be nebulized with drug adrenaline every 6 hours and group II patients will be nebulized with hypertonic saline every 6 hours. After 24 hours and 48 hours of nebulization, researchers will record WDF score by measuring respiratory rate, heart rate, chest retractions, chest auscultation findings and SPO₂ levels. All data will be recorded on a research Performa including length of hospital stay. Data will be entered on SPSS to calculate results. Independent sample t-test was used to measure the effect of two drugs on the length of hospital stay and improvement of respiratory score with a 95% confidence interval. P value less than 0.05 will be considered as significant. ;


Study Design


Related Conditions & MeSH terms

  • Acute Bronchiolitis Due to Respiratory Syncytial Virus
  • Bronchiolitis

NCT number NCT06267118
Study type Interventional
Source Combined Military Hospital, Pakistan
Contact Syed Qamar Zaman
Phone 00923365307823
Email dr.qamarzaman@hotmail.com
Status Recruiting
Phase Phase 3
Start date November 1, 2023
Completion date May 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04519073 - Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus Phase 1